Mandate

Vinge advises Vostok New Ventures Ltd in connection with its in kind acquisition of BlaBlaCar

The acquisition was made by an issue in kind where the purchase price for the shares in BlaBlaCar consisted of 4,154,495 newly issued shares in Vostok. A prospectus for listing of the Swedish depository receipts representing the issued shares was approved by the Swedish Financial Supervisory Authority and made public on 23 November, 2016. The Swedish depository receipts were admitted to trading on Nasdaq Stockholm on 25 November 2016.

Vostok is an investment company with a special focus on online marketplaces and businesses with strong network effects. As of 30 September 2016, the net asset value of the group was USD 632.44 million. The Swedish depository receipts of Vostok are listed on Nasdaq Stockholm, Mid Cap segment.

Vinge’s team primarily consisted of Jesper Schönbeck, David Andersson, Frida Bäckegren, Joel Wahlberg and Sara Osman.

Related

Vinge advises HealthCap in conjunction with an investment in Neobiomics

HealthCap is investing in Neobiomics AB, which develops products in the neonatal field. Neobiomics’ flagship product, Proprems, is a probiotic dietary supplement developed for preterm infants.
May 22, 2026

Vinge advises Sveafastigheter in its merger with KlaraBo

Vinge advises Sveafastigheter AB (publ) in its merger with KlaraBo Sverige AB.
May 22, 2026

Vinge advises Lagercrantz Group in conjunction with the acquisition of Stalon

Lagercrantz Group Aktiebolag has acquired 88 per cent of the shares in Stalon AB, a Swedish manufacturer of silencers for hunting firearms. The company is based in Stalon, which is located outside Vilhelmina, where the company conducts development and production in its own facilities.
May 21, 2026